[{"id":"f998438e-b773-4345-93ac-9c264d1adecf","acronym":"","url":"https://clinicaltrials.gov/study/NCT02646839","created_at":"2021-01-18T12:52:48.002Z","updated_at":"2024-07-02T16:35:31.543Z","phase":"Phase 2","brief_title":"KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children","source_id_and_acronym":"NCT02646839","lead_sponsor":"Michael Pulsipher, MD","biomarkers":" ABL1 • BCR • KIR2DL1","pipe":" | ","alterations":" Chr del(5q)","tags":["ABL1 • BCR • KIR2DL1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Chr del(5q)"],"overall_status":"Enrolling by invitation","enrollment":" Enrollment 50","initiation":"Initiation: 10/01/2015","start_date":" 10/01/2015","primary_txt":" Primary completion: 08/01/2024","primary_completion_date":" 08/01/2024","study_txt":" Completion: 08/01/2024","study_completion_date":" 08/01/2024","last_update_posted":"2023-10-26"}]